The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 115, Issue 2, 2013, Pages 154-159

  Fragoso, Yara Dadalti ^a   Boggild, Mike ^b   MacIas Islas, Miguel Angel ^c   Carra, Adriana ^d   Schaerer, Kirsty Deborah ^e   Aguayo, Adriana ^c   De Almeida, Sandra Maria Garcia ^f   Alvarenga, Marcos Papais ^g   Alvarenga, Regina Maria Papais ^g   Alves Leon, Soniza Vieira ^f   Arruda, Walter Oleschko ^h   Brooks, Joseph Bruno Bidin ^a   Comini Frota, Elizabeth Regina ⁱ   Ferreira, Maria Lucia Brito ^j   Finkelsztejn, Alessandro ^k   Finkelsztejn, Juliana Marcon Szymanski ^k   De Freitas, Lucas Dias ^j   Gallina, Andre Serafin ^l   Da Gama, Paulo Diniz ^m   Georgetto, Sergio ⁿ   Giacomo, Maria Cristina B ^l   Gomes, Sidney ^o,p   Gonçalves, Marcus Vinicius Magno ^q   Grzesiuk, Anderson Kuntz ^r   Kaimen Maciel, Damacio Ramon ⁿ   Lopes, Josiane ⁿ   Lourenco, Giselle A ^f   Malfetano, Fabiola Rachid ^g   Morales, Nivea MacEdo Oliveira ^s   Morales, Rogerio De Rizo ^s   Oliveira, Celso Luis Silva ^a   Onaha, Patricia ^d   Patroclo, Cristiane ^g   Ribeiro, Sonia Beatriz Felix ^t   Ribeiro, Taysa Alexandrino Gonsalves Jube ^u   Salminen, Heidi Johanna ^v   Santoro, Patricia ^w   Seefeld, Marcos ^x   Soares, Paula Vallegas ^a   Tarulla, Adriana ^w   Vasconcelos, Claudia Cristina Ferreira ^g   more..

^a UNIVERSIDADE METROPOLITANA DE SANTOS   (Brazil)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

^d HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^h FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

ⁱ FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^j HOSPITAL DA RESTAURAÇÃO   (Brazil)

^k HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^l Campus Sorocaba ^*

^m PONTIFÍCIA UNIVERSIDADE CATÓLICA DE SÃO PAULO   (Brazil)

ⁿ STATE UNIVERSITY OF LONDRINA   (Brazil)

^o HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^p Services of Radiology of Hospital Nove de Julho   (Brazil)

^q Clinica Neurologica   (Brazil)

^r Hospital Santa Rosa   (Brazil)

^s FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^t FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^u Instituto de Investigaciones Medicas Dr Alfredo Lanari   (Brazil)

^v BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^w INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^x Hospital Universitario da Faculdade Evangelica Do Paraná   (Brazil)

more..

Author keywords

Glatiramer acetate; Interferon beta; Multiple sclerosis; Pregnancy

Indexed keywords

AMOXICILLIN; BETA INTERFERON; CLONAZEPAM; CORTICOSTEROID; FLUOXETINE; FOLIC ACID; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BREECH PRESENTATION; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODIFYING THERAPY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; HYPEREMESIS GRAVIDARUM; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEWBORN DEATH; NEWBORN JAUNDICE; NUCHAL CORD; PHARMACEUTICAL CARE; PLACENTA PREVIA; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN HEMANGIOMA; SPONTANEOUS ABORTION; TREATMENT INDICATION; TWIN PREGNANCY;

ADULT; ARGENTINA; BRAZIL; BREAST FEEDING; CESAREAN SECTION; DATABASES, FACTUAL; DELIVERY, OBSTETRIC; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTERFERONS; MALE; MEXICO; MULTIPLE SCLEROSIS; OBSTETRIC LABOR COMPLICATIONS; PEPTIDES; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84872295057     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.04.024     Document Type: Article

References (19)

1. M. Hutchinson Safety first, efficacy second in disease modifying therapies Multiple Sclerosis 17 2011 380 381
2. M. Koch, M. Uyttenboogaart, D. Heersema, C. Steen, and J. De Keyser Parity and secondary progression in multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry 80 2009 676 678
3. L. Prosperini, C. Giannì, L. Leonardi, L. De Giglio, G. Borriello, and S. Galgani Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis Multiple Sclerosis 18 2012 64 71
4. D. Cadavid, S. Kim, B. Peng, J. Skurnick, M. Younes, and J. Hill Clinical consequences of MRI activity in treated multiple sclerosis Multiple Sclerosis 17 2011 1113 1121
5. A. Finkelsztejn, J.B. Brooks, F.M. Paschoal Jr., and Y.D. Fragoso What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature BJOG 118 2011 790 797
6. C. Schaefer, D. Hannemann, and R. Meister Post-marketing surveillance system for drugs in pregnancy-15 years' experience of ENTIS Reproductive Toxicology 20 2005 331 343
7. H.J. Salminen, H. Leggett, and M. Boggild Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes Journal of Neurology 257 2010 2020 2023
8. Y.D. Fragoso, A. Finkelsztejn, D.R. Kaimen-Maciel, A.K. Grzesiuk, A.S. Gallina, and J. Lopes Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series CNS Drugs 24 2010 969 976
9. M. Sandberg-Wollheim, E. Alteri, M.S. Moraga, and G. Kornmann Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy Multiple Sclerosis 17 2011 423 430
10. M.P. Amato, E. Portaccio, A. Ghezzi, B. Hakiki, V. Zipoli, and V. Martinelli Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis Neurology 75 2010 1794 1802
11. K. Hellwig, A. Haghikia, and R. Gold Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment Multiple Sclerosis 17 2011 958 963
12. S. Ferrero, F. Esposito, S. Pretta, and N. Ragni Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding Expert Review of Neurotherapeutics 6 2006 1823 1831
13. T. Berger Current therapeutic recommendations in multiple sclerosis Journal of the Neurological Sciences 287 Suppl. 1 2009 S37 S45
14. Association of British Neurologists. Revised-Guidelines for Prescribing in Multiple Sclerosis; 2009. Available at: http://www.abn.org.uk.
15. N. Adab, U. Kini, J. Vinten, J. Ayres, G. Baker, and J. Clayton-Smith The longer term outcome of children born to mothers with epilepsy Journal of Neurology, Neurosurgery, and Psychiatry 75 2004 1575 1583
16. C. Weber-Schoendorfer, and C. Schaefer Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study Multiple Sclerosis 15 2009 1037 1042
17. F. Patti, T. Cavallaro, S. Lo Fermo, A. Nicoletti, V. Cimino, and R. Vecchio Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? Journal of Neurology 255 2008 1250 1253
18. A.J. Barros, I.S. Santos, A. Matijasevich, M.R. Domingues, M. Silveira, and F.C. Barros Patterns of deliveries in a Brazilian birth cohort: almost universal cesarean sections for the better-off Revista de Saude Publica 45 2011 635 643
19. M.B. Nascimento, M.A. Reis, S.C. Franco, H. Issler, A.A. Ferraro, and S.J. Grisi Exclusive breastfeeding in southern Brazil: prevalence and associated factors Breastfeeding Medicine 5 2010 79 85